Vivos (RDGL) Total Debt Growth (1y) (2011 - 2019)
Vivos (RDGL) Total Debt Growth (1y) (2011 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 142.67% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -9.88% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 1,188.16% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 0.12% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -17.79% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -9.03% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -0.50% |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 7,741.27% |
| Sep 30, 2018 | -91.59% |
| Mar 31, 2018 | -89.58% |
| Sep 30, 2017 | 15.53% |
| Jun 30, 2017 | 15.53% |
| Mar 31, 2017 | -71.15% |
| Dec 31, 2016 | -74.06% |
| Sep 30, 2016 | -68.53% |
| Jun 30, 2016 | -92.67% |
| Mar 31, 2016 | 42.15% |
| Dec 31, 2015 | -71.29% |
| Sep 30, 2015 | 106.12% |
| Jun 30, 2015 | 676.71% |
| Mar 31, 2015 | 167.44% |
| Dec 31, 2014 | 901.71% |
| Sep 30, 2014 | 44.64% |
| Jun 30, 2014 | 98.78% |
| Dec 31, 2013 | 418.67% |
| Sep 30, 2013 | 464.13% |
| Jun 30, 2013 | 154.88% |